Treatment of Unruptured Intracranial Aneurysms in China

NCT03133598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5126

Last updated 2024-09-23

No results posted yet for this study

Summary

Un-ruptured intracranial aneurysm is a complex disease that seriously affects human life and health. At present, the treatment of intracranial aneurysm is divided into interventional treatment and craniotomy clipping, the two treatment methods are different in the intervention effect of aneurysm, for example, the complications of interventional therapy are lower than craniotomy clipping, but the long-term patency rate is lower than craniotomy clipping, and there is no standard of treatment in different parts of aneurysm in our country, the choice of intervention measures of un-ruptured aneurysm is different in different clinical centers; on the other hand, there are serious problems in the treatment of aneurysms, because without the relevant guidelines of diagnosis and treatment of intracranial aneurysms, different clinical centers will cause excessive treatment of un-ruptured aneurysms, not only bring unreasonable utilization of medical resources, but also cause the subject's life and property to be threatened.

The patients with un-ruptured intracranial aneurysm(estimated sample number over 1500) were included in prospective cohort study, after clipping and intervention operation, setting fixed time for postoperative follow-up, the clinical data and image data were recorded, the safety, efficacy and economic benefits of interventional treatment and craniotomy clipping were compared, providing strategies for the standardized treatment of un-ruptured intracranial aneurysms.

Conditions

  • Intracranial Aneurysm
  • Stent Embolisation
  • Craniotomy
  • Coil-assissted Embolisation
  • Covered Stent
  • Woven EndoBridge

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • Beijing Tiantan Hospital

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • The Affiliated Hospital Of Southwest Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Shenzhen Second People's Hospital

    collaborator OTHER
  • Guangdong 999 Brain Hospital

    collaborator OTHER
  • Shantou Central Hospital

    collaborator OTHER
  • ZhuHai Hospital

    collaborator OTHER
  • Zhongshan Hospital Of Traditional Chinese Medicine

    collaborator OTHER
  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Eighth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Chuanzhi Duan, Ph.D. · Department of Neurosurgery, Southern Medical University, Zhujiang Hospital

Eligibility

Min Age
14 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133598 on ClinicalTrials.gov